Medicare Enrolled

Dr. Pavlo Sakhatskyy, M.D.

Pulmonary Disease · Safety Harbor, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
1840 MEASE DR, Safety Harbor, FL 34695
7277256128
In practice since 2007 (18 years)
NPI: 1245430222 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sakhatskyy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sakhatskyy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sakhatskyy

Dr. Pavlo Sakhatskyy is a pulmonary disease in Safety Harbor, FL, with 18 years in practice. Based on federal Medicare data, Dr. Sakhatskyy performed 885 Medicare services across 609 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sakhatskyy received a total of $18,424 from 52 pharmaceutical and/or device companies across 236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sakhatskyy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ 885 Medicare services$ $18,424 industry payments

Medicare Practice Summary

Medicare Utilization ↗
885
Medicare services
Bottom 42% in FL for pulmonary disease
609
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~49 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity312$94$265
Critical care, first 30-74 min144$170$502
Initial hospital admission, high complexity143$134$401
Office visit, established patient (30-39 min)94$95$186
Office visit, established patient (20-29 min)70$61$131
Hospital follow-up visit, moderate complexity52$61$193
Test to measure expiratory airflow and volume changes before and after medication administration15$29$55
Test to determine lung volumes using gas dilution or washout15$33$85
Test to examine how well the lungs exchange gases15$43$80
New patient office visit (45-59 min)13$121$244
New patient office visit (30-44 min)12$82$164
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$18,424
Total received (2018-2024)
Avg $2,632/year across 7 years
Top 12% in FL for pulmonary disease
52
Companies
236
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12,951 (70.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,473 (29.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,376
2023
$13,774
2022
$755
2021
$710
2020
$302
2019
$997
2018
$509

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Intuitive Surgical, Inc.
$12,951
INTUITIVE SURGICAL, INC.
$675
GlaxoSmithKline, LLC.
$633
Boehringer Ingelheim Pharmaceuticals, Inc.
$530
AstraZeneca Pharmaceuticals LP
$508
Actelion Pharmaceuticals US, Inc.
$397
Inari Medical, Inc.
$250
Novartis Pharmaceuticals Corporation
$222
Amgen Inc.
$183
Shionogi Inc
$166
Janssen Pharmaceuticals, Inc
$126
United Therapeutics Corporation
$123
Takeda Pharmaceuticals U.S.A., Inc.
$112
Sunovion Pharmaceuticals Inc.
$103
Philips Electronics North America Corporation
$94
Mallinckrodt Hospital Products Inc.
$88
Insmed, Inc.
$87
Advanced Respiratory, Inc
$74
GENZYME CORPORATION
$72
Mylan Specialty L.P.
$71
Regeneron Healthcare Solutions, Inc.
$67
Bayer HealthCare Pharmaceuticals Inc.
$65
Inogen, Inc.
$53
Grifols USA, LLC
$49
Acerta Pharma LLC
$49
Pulmonx Corporation
$41
PORTOLA PHARMACEUTICALS, INC.
$41
Shire North American Group Inc
$39
CSL Behring
$37
Covis Pharma GmBH
$36
Allergan Inc.
$34
ABBVIE INC.
$33
Bayer Healthcare Pharmaceuticals Inc.
$29
Nabriva Therapeutics, plc
$28
Melinta Therapeutics, Inc.
$28
AbbVie Inc.
$27
Teva Pharmaceuticals USA, Inc.
$24
Ethicon Inc.
$23
Sandoz Inc.
$22
Theravance Biopharma, Inc.
$21
Baxter Healthcare
$21
Circassia Pharmaceuticals Inc
$20
Merck Sharp & Dohme Corporation
$20
Vapotherm Inc
$19
Mallinckrodt LLC
$19
Philips North America LLC
$19
ADVANCED RESPIRATORY, INC
$18
Gilead Sciences, Inc.
$17
Allergan, Inc.
$17
Electromed, Inc.
$15
Resmed Corp
$15
PFIZER INC.
$14
Top 3 companies account for 77.4% of total payments
Associated products mentioned in payments ›
(8874) inCourage · (AE4) Secretion Management · ACTHAR · AIRSENSE · AIRSUPRA · ANDEXXA · ANORO · AREXVY · AVYCAZ · Adempas · Arikayce · BREO · BREZTRI · Baxdela · CHANTIX · CHARTIS CATHETER · CINQAIR · CUVITRU · DUPIXENT · Da Vinci Surgical System · DreamWear · FASENRA · FLOWTRIEVER CATHETER · Fetroja · FlowTriever · GLASSIA · Hillrom - Vest System Model 105 Home Care · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · ION · InogenOne · Kcentra · LONHALA MAGNAIR · Monarch Platform · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Prolastin-C Liquid · S · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TAVNEOS · TEZSPIRE · TRELEGY ELLIPTA · TREPROSTINIL · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · UTIBRON · Utibron · VAPOTHERM · VIBATIV · XARELTO · XOLAIR · Xenleta · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (70%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $2,082 per 100 Medicare services performed
Looking for a pulmonary disease in Safety Harbor?
Compare pulmonary diseases in the Safety Harbor area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
99
Per 100K population
10.3
County median income
$70,293
Nearest hospital
MEASE COUNTRYSIDE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sakhatskyy is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 12%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sakhatskyy experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Sakhatskyy performed 312 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sakhatskyy receive payments from pharmaceutical companies?
Yes. Dr. Sakhatskyy received a total of $18,424 from 52 companies across 236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sakhatskyy's costs compare to other pulmonary diseases in Safety Harbor?
Dr. Sakhatskyy's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sakhatskyy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →